Difference between revisions of "Selumetinib (Koselugo)"
Jump to navigation
Jump to search
(Created page with "==Diseases for which it is used== *Acute myeloid leukemia Category:Investigational Category:Kinase inhibitors Category:MEK inhibitors") |
m |
||
| Line 1: | Line 1: | ||
| + | ==Mechanism of action== | ||
| + | Inhibits the enzyme MAPK kinase (MEK), specifically the MEK1 and MEK2 subtypes of the enzyme. | ||
| + | |||
==Diseases for which it is used== | ==Diseases for which it is used== | ||
*[[Acute myeloid leukemia]] | *[[Acute myeloid leukemia]] | ||
| Line 5: | Line 8: | ||
[[Category:Kinase inhibitors]] | [[Category:Kinase inhibitors]] | ||
[[Category:MEK inhibitors]] | [[Category:MEK inhibitors]] | ||
| + | |||
| + | [[Category:Acute myeloid leukemia medications]] | ||
Revision as of 15:10, 19 September 2014
Mechanism of action
Inhibits the enzyme MAPK kinase (MEK), specifically the MEK1 and MEK2 subtypes of the enzyme.